Is VELO FDA Approved? VELO's PMTA Status Explained
Twenty-four VELO nicotine pouch products received FDA authorization in October 2026. Learn which VELO SKUs are authorized and which are not.
Twenty-four VELO nicotine pouch products received FDA marketing authorization on October 30, 2026. The authorized products are all 4mg Mini Pouch and Mini Pouch 2 variants in eight flavors across three packaging configurations. Popular VELO products like Citrus 4mg and Spearmint 7mg remain under FDA review without authorization as of November 2026.
In one sentence: As of October 2026, twenty-four VELO Mini Pouch products in 4mg strength are FDA authorized, while other VELO variants remain pending FDA review.
What FDA Authorization Means for VELO
According to the FDA's October 30, 2026 authorization decision, VELO nicotine pouches from Modoral Brands Inc. (a Reynolds American/BAT subsidiary) have met the agency's standards for premarket review. VELO's FDA authorization covers specific Mini Pouch and Mini Pouch 2 products, not the entire brand line.
FDA authorization means these VELO products have completed the Premarket Tobacco Application (PMTA) process. The FDA determined that marketing these specific products is "appropriate for the protection of public health" under the Family Smoking Prevention and Tobacco Control Act. This does not mean VELO products are safe or approved by the FDA—the agency does not approve tobacco products. Authorization only means these products may be legally marketed in the United States.
VELO joins ZYN and on! PLUS as the only nicotine pouch brands with FDA-authorized products as of November 2026. ZYN received authorization for all 31 SKUs in January 2025. on! PLUS has 12 authorized SKUs. Other nicotine pouch brands including Rogue, FRE, and Lucy have submitted PMTAs but have not received FDA marketing authorization.
Which VELO Products Are FDA Authorized?
The FDA's October 2026 authorization covers twenty-four VELO products manufactured by Modoral Brands Inc. All authorized products are 4mg strength in Mini Pouch or Mini Pouch 2 formats.
VELO Mini Pouch at 4mg authorized flavors:
- Crema
- Lime
- Orange Crema
- Passion Fruit
VELO Mini Pouch 2 at 4mg authorized flavors:
- Crema
- Lime
- Orange Crema
- Cinnamon
Each flavor is available in three packaging configurations, totaling twenty-four authorized products. The authorization applies only to products manufactured by Modoral Brands Inc. at approved facilities.
| Product Line | Flavor | Strength | FDA Status |
|---|---|---|---|
| VELO Mini Pouch | Crema | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch | Lime | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch | Orange Crema | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch | Passion Fruit | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch 2 | Crema | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch 2 | Lime | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch 2 | Orange Crema | 4mg | FDA Authorized (Oct 2026, PMTA) |
| VELO Mini Pouch 2 | Cinnamon | 4mg | FDA Authorized (Oct 2026, PMTA) |
Which VELO Products Are NOT Authorized?
Many widely available VELO products have submitted PMTAs but have not received FDA marketing authorization as of November 2026.
VELO Citrus 4mg remains under FDA review. VELO Citrus 4mg is not among the authorized products despite its 4mg strength matching the authorized Mini Pouch line. VELO Citrus 4mg has submitted a PMTA but has not yet received FDA marketing authorization. This product contains 20 pouches per can and remains available for purchase during the review period.
VELO Spearmint 7mg is not FDA authorized. VELO Spearmint 7mg has a PMTA pending review but lacks marketing authorization. The 7mg strength was not included in the October 2026 authorization batch.
Other VELO variants in higher strengths (7mg, 11mg) and different formats are also not included in the October 2026 authorization. These products have submitted PMTAs and remain available for sale while under FDA review. The FDA evaluates each SKU individually based on formulation, user data, and public health impact. Authorization of one VELO product does not automatically extend to other strengths, flavors, or formats.
What This Means for VELO Users 21 and Older
VELO users 21 and older can continue purchasing both authorized and non-authorized products. Products with pending PMTAs remain legal to sell during the FDA review period, which can extend several years.
The key difference is regulatory certainty. VELO Mini Pouch and Mini Pouch 2 4mg variants have completed the PMTA process and received explicit FDA authorization. These products have documented approval to remain on the market indefinitely unless formulation or marketing changes occur.
For adult consumers 21 and older who prefer VELO's non-authorized flavors like Citrus or higher strengths like 7mg, those products remain widely available. The FDA has not issued marketing denial orders for VELO products outside the authorized list. Retailers continue stocking the full VELO product line.
Retailers benefit from the October 2026 authorization because it provides regulatory confidence for the twenty-four authorized SKUs. These products will not face unexpected market removal based on PMTA review outcomes.
The PMTA Process for VELO
VELO's manufacturer, Modoral Brands Inc., submitted PMTAs for multiple VELO products beginning in 2020. The FDA's review process for nicotine pouches evaluates product formulation, nicotine delivery characteristics, user behavior data, youth appeal factors, marketing plans, and overall public health impact.
According to Reynolds American's October 30, 2026 announcement, the FDA authorization followed an extensive review of scientific data submitted by Modoral Brands Inc. The agency examined whether marketing VELO Mini Pouch products would benefit adult tobacco users 21 and older seeking alternatives while limiting appeal to youth and non-users.
VELO's authorization rate differs significantly from ZYN's outcome. ZYN received authorization for all 31 submitted products (15 SKUs at 3mg and 6mg strengths). VELO received authorization for twenty-four products in one product line at a single 4mg strength, while other variants remain under review. This suggests the FDA applied different standards or found distinct public health considerations for VELO's higher-strength and non-Mini Pouch products.
The PMTA process typically requires two to three years from submission to final decision. VELO's October 2026 authorizations likely represent PMTAs submitted in 2023 or 2024. Products submitted earlier may still be under review due to the complexity of nicotine pouch evaluation.
VELO products not yet authorized may receive decisions in future FDA announcement cycles. The FDA continues reviewing pending nicotine pouch PMTAs on a rolling basis, with no fixed timeline for decisions. Some applications receive authorization, others receive marketing denial orders, and many remain in extended review.
VELO Compared to Other FDA-Authorized Brands
VELO's partial authorization differs from the outcomes for ZYN and on! PLUS. ZYN received authorization for its entire product line—all flavors and both strength levels submitted. on! PLUS received authorization for 12 products across three flavors (Mint, Tobacco, Wintergreen) in 6mg and 9mg strengths with 20 pouches per can.
VELO's 4mg strength positions the authorized products at a lower nicotine level than many competitors. ZYN offers 3mg and 6mg options. on! PLUS offers 6mg and 9mg. VELO's non-authorized variants include 7mg and 11mg products that compete directly with higher-strength options from other brands.
The Mini Pouch format that received authorization represents a specific product design choice by Modoral Brands Inc. The compact pouch size and 4mg strength may have addressed FDA concerns about nicotine delivery patterns or youth appeal that affected VELO's standard-format products.
For adult nicotine pouch users 21 and older comparing FDA-authorized options, VELO Mini Pouch products now join ZYN and on! PLUS as verified alternatives. Users who prioritize regulatory certainty have three brand choices with documented FDA authorization.
For the complete list of FDA-authorized nicotine pouches including all ZYN and on! PLUS products, see our FDA PMTA Tracker. Read more about VELO's full product line at VELO brand overview.